From sugar to fat: How the transcription factor XBP1 regulates hepatic lipogenesis

Annals of the New York Academy of Sciences

Volumn 1173, Issue SUPPL. 1, 2009, Pages

  Glimcher, Laurie H ^a,b   Lee, Ann Hwee ^a  

^a HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

^b HARVARD MEDICAL SCHOOL   (United States)

Author keywords

cholesterol; dyslipidemia; lipogenesis; liver; transcription; triglycerides; XBP1

Indexed keywords

X BOX BINDING PROTEIN 1; CARBOHYDRATE; CHOLESTEROL; DNA BINDING PROTEIN; FATTY ACID; LIPID; MESSENGER RNA; REGULATORY FACTOR X TRANSCRIPTION FACTORS; TRANSCRIPTION FACTOR; TRIACYLGLYCEROL;

ALCOHOL LIVER DISEASE; ATHEROSCLEROSIS; CARBOHYDRATE DIET; DYSLIPIDEMIA; FATTY ACID SYNTHESIS; GENE DELETION; HUMAN; HYPOCHOLESTEROLEMIA; LIPID COMPOSITION; LIPID STORAGE; LIPOGENESIS; LIVER; METABOLIC SYNDROME X; MORBIDITY; MORTALITY; NONALCOHOLIC FATTY LIVER; NONHUMAN; PHENOTYPE; PROTEIN EXPRESSION; PROTEIN SECRETION; REVIEW; ADULT; BIOSYNTHESIS; DRUG EFFECT; GENE; GENETICS; INSULIN RESISTANCE; METABOLIC DISORDER; METABOLISM; OBESITY; PHYSIOLOGY;

ADULT; CARBOHYDRATES; CHOLESTEROL; DIETARY CARBOHYDRATES; DNA-BINDING PROTEINS; DYSLIPIDEMIAS; FATTY ACIDS; GENES, MHC CLASS II; HUMANS; INSULIN RESISTANCE; LIPIDS; LIVER; METABOLIC DISEASES; METABOLIC SYNDROME X; OBESITY; RNA, MESSENGER; TRANSCRIPTION FACTORS; TRIGLYCERIDES;

EID: 70350459324     PISSN: 00778923     EISSN: 17496632     Source Type: Book Series    
DOI: 10.1111/j.1749-6632.2009.04956.x     Document Type: Review

References (65)

1. Lee, A.-H., E.F. Scapa, D.E. Cohen & L.H. Glimcher. 2008. Regulation of hepatic lipogenesis by the transcription factor XBP1. Science 320: 1492-1496.
2. Mensah, G.A., A.H. Mokdad, E. Ford, et al. 2004. Obesity, metabolic syndrome, and type 2 diabetes: emerging epidemics and their cardiovascular implications. Cardiol. Clin. 22: 485-504.
3. Ginsberg, H.N., Y.L. Zhang & A. Hernandez-Ono. 2006. Metabolic syndrome: focus on dyslipidemia. Obesity (Silver Spring) 14(Suppl 1): 41S-49S.
4. Ginsberg, H.N. 2000. Insulin resistance and cardiovascular disease. J. Clin. Invest. 106: 453-458.
5. Ferre, P. & F. Foufelle. 2007. SREBP-1c transcription factor and lipid homeostasis: clinical perspective. Horm. Res. 68: 72-82.
6. Horton, J.D., J.L. Goldstein & M.S. Brown. 2002. SREBPs: activators of the complete program of cholesterol and fatty acid synthesis in the liver. J. Clin. Invest. 109: 1125-1131.
7. Shimomura, I., M. Matsuda, R.E. Hammer, et al. 2000. Decreased IRS-2 and increased SREBP-1c lead to mixed insulin resistance and sensitivity in livers of lipodystrophic and ob/ob mice. Mol. Cell. 6: 77-86.
8. Brunzell, J.D. 2007. Clinical practice. Hypertriglyceridemia. N. Engl. J. Med. 357: 1009-1017.
9. Ron, D. & P. Walter. 2007. Signal integration in the endoplasmic reticulum unfolded protein response. Nat. Rev. Mol. Cell Biol. 8: 519-529.
10. Shen, X., R.E. Ellis, K. Lee, et al. 2001. Complementary signaling pathways regulate the unfolded protein response and are required for C. elegans development. Cell 107: 893-903.
11. Calfon, M., H. Zeng, F. Urano, et al. 2002. IRE1 couples endoplasmic reticulum load to secretory capacity by processing the XBP-1 mRNA. Nature 415: 92-96.
12. Yoshida, H., T. Matsui, A. Yamamoto, et al. 2001. XBP1 mRNA is induced by ATF6 and spliced by IRE1 in response to ER stress to produce a highly active transcription factor. Cell 107: 881-891.
13. Cox, J.S., C.E. Shamu & P. Walter. 1993. Transcriptional induction of genes encoding endoplasmic reticulum resident proteins requires a transmembrane protein kinase. Cell 73: 1197-1206.
14. Lee, K., W. Tirasophon, X. Shen, et al. 2002. IRE1- mediated unconventional mRNA splicing and S2Pmediated ATF6 cleavage merge to regulate XBP1 in signaling the unfolded protein response. Genes Dev. 16: 452-466.
15. Shaffer,A.L., M. Shapiro-Shelef,N.N. Iwakoshi, et al. 2004. XBP1, downstream of Blimp-1, expands the secretory apparatus and other organelles, and increases protein synthesis in plasma cell differentiation. Immunity 21: 81-93.
16. Lee, A.H., N.N. Iwakoshi & L.H. Glimcher. 2003. XBP-1 regulates a subset of endoplasmic reticulum resident chaperone genes in the unfolded protein response. Mol. Cell. Biol. 23: 7448-7459.
17. Acosta-Alvear, D., Y. Zhou, A. Blais, et al. 2007. XBP1 controls diverse cell type- and conditionspecific transcriptional regulatory networks. Mol. Cell. 27: 53-66.
18. Niwa, M., C.K. Patil, J. DeRisi & P. Walter. 2005. Genome-scale approaches for discovering novel nonconventional splicing substrates of the Ire1 nuclease. Genome Biol. 6: R3.
19. Zhang, K., H.N. Wong, B. Song, et al. 2005. The unfolded protein response sensor IRE1alpha is required at 2 distinct steps in B cell lymphopoiesis. J. Clin. Invest. 115: 268-281.
20. Hollien, J.&J.S.Weissman. 2006. Decay of endoplasmic reticulum-localized mRNAs during the unfolded protein response. Science 313: 104-107.
21. Lee, A.H., N.N. Iwakoshi, K.C. Anderson & L.H. Glimcher. 2003. Proteasome inhibitors disrupt the unfolded protein response inmyeloma cells. Proc. Natl. Acad. Sci. USA 100: 9946-9951.
22. Yoshida, H., M. Oku, M. Suzuki & K. Mori. 2006. pXBP1(U) encoded in XBP1 pre-mRNA negatively regulates unfolded protein response activator pXBP1(S) in mammalian ER stress response. J. Cell. Biol. 172: 565-575.
23. Yoshida, H., T. Matsui, N. Hosokawa, et al. 2003. A time-dependent phase shift in the mammalian unfolded protein response. Dev. Cell. 4: 265-271.
24. Lee, A.H., G.C. Chu, N.N. Iwakoshi & L.H. Glimcher. 2005. XBP-1 is required for biogenesis of cellular secretory machinery of exocrine glands. Embo J. 24: 4368-4380.
25. Iwakoshi, N.N., A.H. Lee, P. Vallabhajosyula, et al. 2003. Plasma cell differentiation and the unfolded protein response intersect at the transcription factor XBP-1. Nat. Immunol. 4: 321-329.
26. Reimold, A.M., A. Etkin, I. Clauss, et al. 2000. An essential role in liver development for transcription factor XBP-1. Genes Dev. 14: 152-157.
27. Towle, H.C., E.N. Kaytor & H.M. Shih. 1997. Regulation of the expression of lipogenic enzyme genes by carbohydrate. Annu. Rev. Nutr. 17: 405-433.
28. Davidson, N.O. & G.S. Shelness. 2000. APOLIPOPROTEIN B: mRNA editing, lipoprotein assembly, and presecretory degradation. Annu. Rev. Nutr. 20: 169-193.
29. Uyeda, K. & J.J. Repa. 2006. Carbohydrate response element binding protein, ChREBP, a transcription factor coupling hepatic glucose utilization and lipid synthesis. Cell Metab. 4: 107-110.
30. Kim, J.B., P. Sarraf, M. Wright, et al. 1998. Nutritional and insulin regulation of fatty acid synthetase and leptin gene expression throughADD1/SREBP1. J. Clin. Invest. 101: 1-9.
31. Kawaguchi, T., M. Takenoshita, T. Kabashima & K. Uyeda. 2001. Glucose and cAMP regulate the L-type pyruvate kinase gene by phosphorylation/ dephosphorylation of the carbohydrate response element binding protein. Proc. Natl. Acad. Sci. USA 98: 13710-13715.
32. Mitro, N., P.A. Mak, L. Vargas, et al. 2007. The nuclear receptor LXR is a glucose sensor. Nature 445: 219-223.
33. Brown, M.S. & J.L. Goldstein. 1997. The SREBP pathway: regulation of cholesterol metabolism by proteolysis of a membrane-bound transcription factor. Cell 89: 331-340.
34. Goldstein, J.L., R.B. Rawson & M.S. Brown. 2002. Mutant mammalian cells as tools to delineate the sterol regulatory element-binding protein pathway for feedback regulation of lipid synthesis. Arch. Biochem. Biophys. 397: 139-148.
35. Brown, A.J., L. Sun, J.D. Feramisco, et al. 2002. Cholesterol addition to ER membranes alters conformation of SCAP, the SREBP escort protein that regulates cholesterol metabolism. Mol. Cell. 10: 237-245.
36. Matsuda, M., B.S. Korn, R.E. Hammer, et al. 2001. SREBP cleavage-activating protein (SCAP) is required for increased lipid synthesis in liver induced by cholesterol deprivation and insulin elevation. Genes Dev. 15: 1206-1216.
37. Foretz,M., C. Guichard, P. Ferre & F. Foufelle. 1999. Sterol regulatory element binding protein-1c is a major mediator of insulin action on the hepatic expression of glucokinase and lipogenesis-related genes. Proc. Natl. Acad. Sci. USA 96: 12737-12742.
38. Horton, J.D., Y. Bashmakov, I. Shimomura & H. Shimano. 1998. Regulation of sterol regulatory element binding proteins in livers of fasted and refed mice. Proc. Natl. Acad. Sci. USA 95: 5987-5992.
39. Janowski, B.A., B. Shan & D.W. Russell. 2001. The hypocholesterolemic agent LY295427 reverses suppression of sterol regulatory element-binding protein processing mediated by oxysterols. J. Biol. Chem. 276: 45408-45416.
40. Azzout-Marniche, D., D. Becard, C. Guichard, et al. 2000. Insulin effects on sterol regulatory-elementbinding protein-1c (SREBP-1c) transcriptional activity in rat hepatocytes. Biochem. J. 350(Pt 2): 389-393.
41. Fleischmann, M. & P.B. Iynedjian. 2000. Regulation of sterol regulatory-element binding protein 1 gene expression in liver: role of insulin and protein kinase B/cAkt. Biochem. J. 349: 13-17.
42. Lehmann, J.M., S.A. Kliewer, L.B. Moore, et al. 1997. Activation of the nuclear receptor LXR by oxysterols defines a new hormone response pathway. J. Biol. Chem. 272: 3137-3140.
43. Yang, J., J.L. Goldstein, R.E. Hammer, et al. 2001. Decreased lipid synthesis in livers of mice with disrupted Site-1 protease gene. Proc. Natl. Acad. Sci. USA 98: 13607-13612.
44. Liang, G., J. Yang, J.D. Horton, et al. 2002. Diminished hepatic response to fasting/refeeding and liver X receptor agonists in mice with selective deficiency of sterol regulatory element-binding protein-1c. J. Biol. Chem. 277: 9520-9528.
45. Mitchell, K.J., K.I. Pinson, O.G. Kelly, et al. 2001. Functional analysis of secreted and transmembrane proteins critical to mouse development. Nat. Genet. 28: 241-249.
46. Shimano,H., J.D. Horton, R.E.Hammer, et al. 1996. Overproduction of cholesterol and fatty acids causes massive liver enlargement in transgenicmice expressing truncated SREBP-1a. J. Clin. Invest. 98: 1575-1584.
47. Shimano,H., J.D. Horton, I. Shimomura, et al. 1997. Isoform 1c of sterol regulatory element binding protein is less active than isoform1a in livers of transgenic mice and in cultured cells. J. Clin. Invest. 99: 846-854.
48. Horton, J.D., I. Shimomura,M.S. Brown, et al. 1998. Activation of cholesterol synthesis in preference to fatty acid synthesis in liver and adipose tissue of transgenic mice overproducing sterol regulatory elementbinding protein-2. J. Clin. Invest. 101: 2331-2339.
49. Yamashita, H., M. Takenoshita, M. Sakurai, et al. 2001. A glucose-responsive transcription factor that regulates carbohydrate metabolism in the liver. Proc. Natl. Acad. Sci. USA 98: 9116-9121.
50. Koo, S.H., A.K. Dutcher & H.C. Towle. 2001. Glucose and insulin function through two distinct transcription factors to stimulate expression of lipogenic enzyme genes in liver. J. Biol. Chem. 276: 9437-9445.
51. Rufo, C., M. Teran-Garcia, M.T. Nakamura, et al. 2001. Involvement of a unique carbohydrateresponsive factor in the glucose regulation of rat liver fatty-acid synthase gene transcription. J. Biol. Chem. 276: 21969-21975.
52. Dentin, R., F. Benhamed, I. Hainault, et al. 2006. Liver-specific inhibition of ChREBP improves hepatic steatosis and insulin resistance in ob/ob mice. Diabetes 55: 2159-2170.
53. Ishii, S., K. Iizuka, B.C. Miller & K. Uyeda. 2004. Carbohydrate response element binding protein directly promotes lipogenic enzyme gene transcription. Proc. Natl. Acad. Sci. USA 101: 15597-15602.
54. Iizuka, K., R.K. Bruick, G. Liang, et al. 2004. Deficiency of carbohydrate response element-binding protein (ChREBP) reduces lipogenesis as well as glycolysis. Proc. Natl. Acad. Sci. USA 101: 7281-7286.
55. Kabashima, T., T. Kawaguchi, B.E. Wadzinski & K. Uyeda. 2003. Xylulose 5-phosphate mediates glucose-induced lipogenesis by xylulose 5-phosphateactivated protein phosphatase in rat liver. Proc. Natl. Acad. Sci. USA 100: 5107-5112.
56. Cox, J.S., R.E. Chapman & P.Walter. 1997. The unfolded protein response coordinates the production of endoplasmic reticulum protein and endoplasmic reticulum membrane. Mol. Biol. Cell. 8: 1805-1814.
57. Sriburi, R., S. Jackowski, K. Mori & J.W. Brewer. 2004. XBP1: a link between the unfolded protein response, lipid biosynthesis, and biogenesis of the endoplasmic reticulum. J. Cell. Biol. 167: 35-41.
58. Ozcan, U., Q. Cao, E. Yilmaz, et al. 2004. Endoplasmic reticulum stress links obesity, insulin action, and type 2 diabetes. Science 306: 457-461.
59. Wang, D., Y.Wei & M.J. Pagliassotti. 2006. Saturated fatty acids promote endoplasmic reticulum stress and liver injury in rats with hepatic steatosis. Endocrinology 147: 943-951.
60. Ota T, Gayet C, Ginsberg HN. 2008. Inhibition of apolipoprotein B100 secretion by lipid-induced hepatic endoplasmic reticulum stress in rodents. J. Clin. Invest. 118: 316-332.
61. Hotamisligil, G.S. 2005. Role of endoplasmic reticulum stress and c-Jun NH2-terminal kinase pathways in inflammation and origin of obesity and diabetes. Diabetes 54(Suppl 2): S73-S78.
62. Chang, B.H.,W. Liao, L. Li, et al. 1999. Liver-specific inactivation of the abetalipoproteinemia gene completely abrogates very low density lipoprotein/low density lipoprotein production in a viable conditional knockout mouse. J. Biol. Chem. 274: 6051-6055.
63. Liao, W., T.Y. Hui, S.G. Young & R.A. Davis. 2003. Blocking microsomal triglyceride transfer protein interferes with apoB secretion without causing retention or stress in the ER. J. Lipid Res. 44: 978-985.
64. Raabe, M.,M.M. Veniant,M.A. Sullivan, et al. 1999. Analysis of the role of microsomal triglyceride transfer protein in the liver of tissue-specific knockout mice. J. Clin. Invest. 103: 1287-1298.
65. Homanics, G.E., T.J. Smith, S.H. Zhang, et al. 1993. Targeted modification of the apolipoprotein B gene results in hypobetalipoproteinemia and developmental abnormalities in mice. Proc. Natl. Acad. Sci. USA 90: 2389-2393.